Plurify is an early-stage, fast-moving biotech building platform technologies to help unlock the next generation of stem cell and gene therapies. Our work targets the most stubborn manufacturing bottlenecks - including the unwanted residual cells and plasmids left behind during cell and gene therapy production - with scalable, precisely targeted solutions. With several Innovate UK grants and strong private backing behind us, we're growing the team.This is a senior, RNA-focused role for a scientist who wants to own a technology and push it to the front of the field.
RNA engineering for biomanufacturing and therapeutics is the core of the position: designing, building and refining RNA to do powerful recent things, and turning deep molecular understanding into platform-defining capabilities.
We're looking for someone driven by delivering world-leading innovation - the kind of person who sets the direction rather than waits for it.You'll bring years of hands-on experience designing and innovating RNA, including developing control elements that function in an RNA context, working with RNA viruses or self-replicating RNA and understanding their biology in depth, and optimising RNA sequence and elements for robust expression and immune interaction.
Experience deploying RNA in iPSCs, T cells and other human cell types is highly desirable.You'd join a tight-knit team of seven and quickly become the internal authority on RNA - the person colleagues turn to, and the one shaping our RNA strategy.
The role is built to grow: as the company scales, we expect this person could grow into a team-leadership position, building and leading RNA engineering.We run on ownership and trust: flexible working, and the freedom to follow strong ideas wherever they serve the mission.
📌 Senior / Principal Scientist - RNA Engineering for Cell and Gene Therapy (Perth)
🏢 ONE NUCLEUS
📍 Perth
Reply to this offer
Impress this employer describing Your skills and abilities, fill out the form below and leave Your personal touch in the presentation letter.